Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
LIAONING PORT
LIAONING PORT (02880.HK): Wholly-Owned Subsidiary Acquires Container Ship "Jifa Beihai" for RMB 81.61 Million, a Connected Transaction
Tags:
LIAONING PORT
02880.HK
acquisition
2026-09-18
LIAONING PORT (02880.HK): Board appoints Liu Cheng as general manager, term to run until end of eighth board term
Tags:
LIAONING PORT
02880.HK
Appointment
2026-09-10
LIAONING PORT(02880.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 884.91 million, YoY decrease of 7.41%
Tags:
LIAONING PORT
02880.HK
NewTimeSpace
2026-08-31
LIAONING PORT (02880.HK): Applies to DCE for iron ore designated delivery warehouse and bonded delivery warehouse qualifications
Tags:
LIAONING PORT
02880.HK
Business Expansion
2026-08-30
LIAONING PORT(02880.HK): Public Float Stands at Approximately 3.67%, Still Below Minimum Requirement; Actively Exploring Remedial Plans
Tags:
LIAONING PORT
02880.HK
Public Float
2026-08-06
Featured News
Research
HK Stock Connect Weekly: HSI Falls 0.22% for the Week, RMB Counters Proposed for Inclusion in Stock Connect, HQVT Surges Over 70%
Research
HK Recently Listed Stocks Weekly: HQVT Surges 95.59%, Z.AI Tops Liquidity at HK$8.30 Billion Average Daily Turnover-20260918
Research
Weekly Hong Kong ETF Average Returns by Manager (Third Week of September 2026)
Research
Weekly Hong Kong ETF Returns Statistics (Third Week of September 2026)
Finance
SHENYANG PUBLIC (00747.HK): Disposes of 100% Equity Interest in Target Company for RMB 2 Million, Expects Gain of About RMB 33.55 Million
Finance
SF INTRA-CITY (09699.HK): Non-Executive Director Lei Yanqun Resigns
Finance
NEWLINK TECH (09600.HK): Termination of Memorandum of Intent on Equity Acquisition; Proposed Acquisition Will Not Proceed
Finance
LANCANG TEA (06911.HK): Subsidiary's RMB 24.9 Million Working Capital Loan Extended by One Year, Company Continues to Provide Guarantee
Overseas
Going Global Weekly: Mainland Companies Flock to Hong Kong Listings, Pharma Globalisation Shifts to Data and Capability Export-20260918
Finance
TRANSTHERA-B (02617.HK): Tinengotinib Included in CSCO Guidelines for Biliary Tract Malignancies (2026)
Scan QR Code
Download App